Zhiai Xu
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Advances in targeted protein degradation and delivery systems.
Journal: Advanced drug delivery reviews
Published: February 13, 2026
The design of activatable photosensitizers and applications in precision immunomodulation.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 30, 2025
Stimuli-activatable protein degraders for targeted cancer therapy: from prodrug design to nanoplatform applications.
Journal: Advanced drug delivery reviews
Published: November 26, 2025
Engineering brain-penetrant PROTACs: Bridging molecular design and CNS delivery.
Journal: Advanced drug delivery reviews
Published: October 31, 2025
A senescent tumor cell-derived nanovesicle directly primes splenic T cells to potentiate cancer radiotherapy.
Journal: Cell reports. Medicine
Published: September 24, 2025
Smart drug delivery platforms reprogramming cancer immune cycle to mitigate immune resistance of pancreatic tumors.
Journal: Advanced drug delivery reviews
Published: March 19, 2025
Polypeptide sono-adjuvant for ultrasound-activatable regulation of innate immunity and cancer vaccination therapy.
Journal: Nature communications
Published: February 01, 2025
POLY-Senolytic nanoplatform for tumor-specific eradication of senescent tumor cells and mitigation of radiotherapy-induced immune resistance of cancer.
Journal: Nature communications
Published: January 11, 2025
Target-switchable nanoprobe based on BRD4 inhibition for induction and dynamic visualization of the mitochondrial apoptotic pathway.
Journal: Biosensors & bioelectronics
Published: August 07, 2024
Tumor-targeted PROTAC prodrug nanoplatform enables precise protein degradation and combination cancer therapy.
Journal: Acta pharmacologica Sinica
Published: December 23, 2023
Last Updated: 09/26/2026